Pharmac said it will cover the GP and prescription fee for patients changing treatment.
Pharmac has today updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier Pfizer, ...
Pharmac has today updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier Pfizer, will be disrupted due to the detection of a contaminant called nitrosamine. “We know that our healthcare sector is currently under a huge amount of strain, and that changing this many people to alternative treatments will add to that strain. People taking Accuretic will need to consult their doctor about an alternative treatment when next due for a prescription.
The medication Accuretic has been contaminated by a cancer-causing substance and those who take it must switch to another drug.
“Pfizer understands the challenges that this situation poses to wholesalers, pharmacies, and patients. And those articles are free. We fully recognise the importance of this medicine to our patients and are committed to ensuring the safety and quality of our medicines.” “We are asking clinicians to move their patients to alternative medicines as soon as possible and we really appreciate the support that we know that both clinicians and pharmacists will provide to their patients.” Although nitrosamine was believed to increase the risk of cancer in those who took it over a sustained period, Medsafe had advised there was a “low risk” to those who took Accuretic. “We want to ensure, first and foremost, that patients can continue to access funded treatment,” she said.
New Zealand's drug buying agency is alerting almost 36,000 people taking a blood pressure medication that they will need to change treatments due to ...
"We are asking clinicians to move their patients to alternative medicines as soon as possible, and we really appreciate the support that we know that both clinicians and pharmacists will provide to their patients." "We know that our healthcare sector is currently under a huge amount of strain, and that changing this many people to alternative treatments will add to that strain. "Medsafe has advised us that there is no immediate risk to people who are taking Accuretic, and they should continue with their treatment until they find an alternative because the risk associated with suddenly halting blood pressure medication exceeds that presented by the contaminant."
A common medicine taken to manage blood pressure is being recalled after it was found to contain a carcinogen.
"There's time for people to make this change" - Lisa Williams People taking Accuretic were being advised to consult their doctor about an alternative treatment when their next prescription was due. "There's time for people to make this change" - Lisa Williams duration 3:11
Pharmac says those taking Accuretic will need to consult with their doctor about an alternative treatment.
"We know that our healthcare sector is currently under a huge amount of strain, and that changing this many people to alternative treatments will add to that strain. "Unfortunately, because it's a global issue, no alternative brand is available in sufficient volumes for New Zealand and that can be verified as being free from contamination. Those taking Accuretic will need to consult with their doctor about an alternative treatment when they're next due for a prescription.
The medication Accuretic has been contaminated by a cancer-causing substance and those who take it must switch to another drug.
“Pfizer understands the challenges that this situation poses to wholesalers, pharmacies, and patients. And those articles are free. We fully recognise the importance of this medicine to our patients and are committed to ensuring the safety and quality of our medicines.” “We are asking clinicians to move their patients to alternative medicines as soon as possible and we really appreciate the support that we know that both clinicians and pharmacists will provide to their patients.” Although nitrosamine was believed to increase the risk of cancer in those who took it over a sustained period, Medsafe had advised there was a “low risk” to those who took Accuretic. “We want to ensure, first and foremost, that patients can continue to access funded treatment,” she said.
Pharmac has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier Pfizer, ...
"We know that our healthcare sector is currently under a huge amount of strain, and that changing this many people to alternative treatments will add to that strain. "Our expert clinical advice is that losartan with hydrochlorothiazide would be an appropriate, currently funded and Medsafe approved, alternative for most patients. Pharmac has updated health care professionals that supply of quinapril with hydrochlorothiazide (branded as Accuretic), from supplier Pfizer, will be disrupted due to the detection of a contaminant called nitrosamine.
Accuretic was recalled in other countries months ago after being contaminated with a cancer-causing substance, but Pharmac didn't tell Kiwi patients.
And those articles are free. News of the contamination was a “total shock to the system”, he said, exacerbated by news Pharmac had been looking into the issue for months. “Pharmac is useless at passing on information that is relevant to the people who are actually taking the medication.” “I’m sick to death of issues with medications that were only pushed for financial reasons in the first place and the fact that the rest of the world knew about the contamination months ago makes me so angry,” she said. Pharmac said it had been aware of the issue for a “few months”, but did not make a statement until Thursday. Pharmac announced on Thursday morning levels of nitrosamine that were “above the acceptable daily intake” had been detected in the medication.